- Home
- DFP vs QTRX Comparison
DFP vs QTRX Comparison
Compare DFP & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFP
- QTRX
- Stock Information
- Founded
- DFP 2013
- QTRX 2007
- Country
- DFP United States
- QTRX United States
- Employees
- DFP N/A
- QTRX N/A
- Industry
- DFP Investment Managers
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- DFP Finance
- QTRX Industrials
- Exchange
- DFP Nasdaq
- QTRX Nasdaq
- Market Cap
- DFP 418.8M
- QTRX 361.0M
- IPO Year
- DFP N/A
- QTRX 2017
- Fundamental
- Price
- DFP $20.27
- QTRX $7.38
- Analyst Decision
- DFP
- QTRX Strong Buy
- Analyst Count
- DFP 0
- QTRX 4
- Target Price
- DFP N/A
- QTRX $23.25
- AVG Volume (30 Days)
- DFP 56.2K
- QTRX 692.6K
- Earning Date
- DFP 01-01-0001
- QTRX 05-06-2025
- Dividend Yield
- DFP 6.73%
- QTRX N/A
- EPS Growth
- DFP N/A
- QTRX N/A
- EPS
- DFP N/A
- QTRX N/A
- Revenue
- DFP N/A
- QTRX $133,809,000.00
- Revenue This Year
- DFP N/A
- QTRX $13.89
- Revenue Next Year
- DFP N/A
- QTRX $14.79
- P/E Ratio
- DFP N/A
- QTRX N/A
- Revenue Growth
- DFP N/A
- QTRX 14.72
- 52 Week Low
- DFP $15.45
- QTRX $6.80
- 52 Week High
- DFP $19.31
- QTRX $27.54
- Technical
- Relative Strength Index (RSI)
- DFP 38.84
- QTRX 43.31
- Support Level
- DFP $20.31
- QTRX $7.16
- Resistance Level
- DFP $20.50
- QTRX $7.87
- Average True Range (ATR)
- DFP 0.18
- QTRX 0.48
- MACD
- DFP -0.03
- QTRX 0.07
- Stochastic Oscillator
- DFP 2.04
- QTRX 60.15
About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.
Flaherty & Crumrine Pref&Inc Allocation is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.